Compliant-Ready LIMS Launched by LabVantage
LabVantage Solutions, the leading provider of laboratory informatics solutions and services, announces the release of LabVantage 8.3, the newest version of its powerful LIMS software and first GxP-compliant solution for data integrity and auditing, to help drug manufacturers conform to the FDA draft guidance on “Data Integrity and Compliance with CGMP.”
The new Dynamic Auditing feature of the LabVantage LIMS platform ensures that companies are able to meet current and proposed regulatory guidance regarding the management of data in temporary memory. New and emerging data integrity standards put forth by the U.S. Food and Drug Administration (FDA), U.K. Medicines and Healthcare Products Regulatory Agency (MHRA), and World Health Organization (WHO) would require the capture of temporary data in electronic records. The FDA draft guidance states that electronic data that will become part of a permanent CGMP record cannot be stored electronically in temporary memory where it could be subject to manipulation.
LabVantage’s Dynamic Auditing tool helps users maintain a clean and complete, GxP-compliant audit trail based on a full history of analytical testing, including:
• Temporary and permanent data
• Changes between temporary and permanent data entries (even before a page is saved) and the reason for the change
• Identity of person entering the data
• Date and time of data entry
• Electronic signatures and mandatory reason for changes
“LabVantage is the only LIMS provider in the market today to proactively update our software to offer a solution for data integrity and auditing,” said Ram Velidi, President at LabVantage Solutions. “We continue to deliver on our promise to customers to provide state-of-the-art technology that is second to none and is at the leading edge of laboratory information management solutions and the evolving regulatory landscape.”
New Functionality for ELN/LES
LabVantage has also expanded its inventory of Laboratory Execution System (LES) worksheets. In addition to the existing LES worksheets based on Test Methods, new LES worksheets are now available for: QC Batch Testing, used during the testing of unknown samples; Instrument Certification, used to maintain and calibrate instruments; and Finished Product Sample Testing, which facilitates the review of multiple analytical tests on a single sample.
Another new tool is LabVantage’s Chemical Viewer, which has been added to the Electronic Laboratory Notebook (ELN) and LES. With the Chemical Viewer, users can upload a chemical file to a designated location or copy it into the control system. The viewer offers an editable graphic rendering of the chemical structure defined in the file.
Other new features of LabVantage 8.3 include:
• Improved reagent integration within the Advanced Batch Control module
• Additional enhancements to array- and plate-handling, specifically with persistent auditing on reasons, activity, and electronic signatures
• Better Storage Explorer capabilities to search for open/empty spaces for new samples.
This article has been republished from materials provided by LabVantage. Note: material may have been edited for length and content. For further information, please contact the cited source.
The Genes That Make Quorn a Fungal Food FavoriteNews
The meat substitute Quorn is derived from a fungus called Fusarium venenatum. A very similar fungus, F. graminearum, is one of the world's most damaging crop diseases. A new genome study shows why one fungus makes food, and the other destroys it.READ MORE
Neural Computer Hears Like HumansNews
Modelling the human senses is an incredibly complex task. Our brains arrange cells into complex hierarchies that process information from our surroundings. Now, a group at MIT have created a model of the human auditory cortex that can hear sounds and music in the same way that humans do.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018